1 Recombinant Human Granulocyte Colony-Stimulating Market Overview 1.1 Product Overview and Scope of Recombinant Human Granulocyte Colony-Stimulating 1.2 Recombinant Human Granulocyte Colony-Stimulating Segment by Type 1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Lenograstim (Granocyte) 1.2.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) 1.2.4 Others 1.3 Recombinant Human Granulocyte Colony-Stimulating Segment by Application 1.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Comparison by Application: (2021-2027) 1.3.2 Chemotherapy Induced Neutropenia 1.3.3 Before Blood Donation 1.3.4 Stem Cell Transplants 1.3.5 Others 1.4 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Estimates and Forecasts 1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue 2016-2027 1.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales 2016-2027 1.4.3 Recombinant Human Granulocyte Colony-Stimulating Market Size by Region: 2016 Versus 2021 Versus 2027 2 Recombinant Human Granulocyte Colony-Stimulating Market Competition by Manufacturers 2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2016-2021) 2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Recombinant Human Granulocyte Colony-Stimulating Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Recombinant Human Granulocyte Colony-Stimulating Manufacturing Sites, Area Served, Product Type 2.5 Recombinant Human Granulocyte Colony-Stimulating Market Competitive Situation and Trends 2.5.1 Recombinant Human Granulocyte Colony-Stimulating Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Recombinant Human Granulocyte Colony-Stimulating Players Market Share by Revenue 2.5.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario by Region 3.1 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country 3.3.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country 3.3.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country 3.4.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country 3.4.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Region 3.5.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region 3.5.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country 3.6.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country 3.6.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country 3.7.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country 3.7.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Analysis by Type 4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021) 4.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2016-2021) 4.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2016-2021) 5 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Analysis by Application 5.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021) 5.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2016-2021) 5.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Amgen 6.1.1 Amgen Corporation Information 6.1.2 Amgen Description and Business Overview 6.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.1.5 Amgen Recent Developments/Updates 6.2 Qilu Pharmaceutical 6.2.1 Qilu Pharmaceutical Corporation Information 6.2.2 Qilu Pharmaceutical Description and Business Overview 6.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.2.5 Qilu Pharmaceutical Recent Developments/Updates 6.3 Shijiazhuang Pharmaceutical 6.3.1 Shijiazhuang Pharmaceutical Corporation Information 6.3.2 Shijiazhuang Pharmaceutical Description and Business Overview 6.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.3.5 Shijiazhuang Pharmaceutical Recent Developments/Updates 6.4 Kyowa Hakko Kirin 6.4.1 Kyowa Hakko Kirin Corporation Information 6.4.2 Kyowa Hakko Kirin Description and Business Overview 6.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.4.5 Kyowa Hakko Kirin Recent Developments/Updates 6.5 Gensci 6.5.1 Gensci Corporation Information 6.5.2 Gensci Description and Business Overview 6.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.5.5 Gensci Recent Developments/Updates 6.6 Amoytop Biotech 6.6.1 Amoytop Biotech Corporation Information 6.6.2 Amoytop Biotech Description and Business Overview 6.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.6.5 Amoytop Biotech Recent Developments/Updates 6.7 Hangzhou Jiuyuan 6.6.1 Hangzhou Jiuyuan Corporation Information 6.6.2 Hangzhou Jiuyuan Description and Business Overview 6.6.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.7.5 Hangzhou Jiuyuan Recent Developments/Updates 6.8 Huaxin 6.8.1 Huaxin Corporation Information 6.8.2 Huaxin Description and Business Overview 6.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.8.5 Huaxin Recent Developments/Updates 6.9 Triprime 6.9.1 Triprime Corporation Information 6.9.2 Triprime Description and Business Overview 6.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.9.5 Triprime Recent Developments/Updates 6.10 Sinovac 6.10.1 Sinovac Corporation Information 6.10.2 Sinovac Description and Business Overview 6.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.10.5 Sinovac Recent Developments/Updates 6.11 Zhaoke 6.11.1 Zhaoke Corporation Information 6.11.2 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Description and Business Overview 6.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.11.5 Zhaoke Recent Developments/Updates 6.12 Kawin 6.12.1 Kawin Corporation Information 6.12.2 Kawin Recombinant Human Granulocyte Colony-Stimulating Description and Business Overview 6.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Kawin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.12.5 Kawin Recent Developments/Updates 7 Recombinant Human Granulocyte Colony-Stimulating Manufacturing Cost Analysis 7.1 Recombinant Human Granulocyte Colony-Stimulating Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating 7.4 Recombinant Human Granulocyte Colony-Stimulating Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Recombinant Human Granulocyte Colony-Stimulating Distributors List 8.3 Recombinant Human Granulocyte Colony-Stimulating Customers 9 Recombinant Human Granulocyte Colony-Stimulating Market Dynamics 9.1 Recombinant Human Granulocyte Colony-Stimulating Industry Trends 9.2 Recombinant Human Granulocyte Colony-Stimulating Growth Drivers 9.3 Recombinant Human Granulocyte Colony-Stimulating Market Challenges 9.4 Recombinant Human Granulocyte Colony-Stimulating Market Restraints 10 Global Market Forecast 10.1 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Type (2022-2027) 10.2 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Application (2022-2027) 10.3 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) Growth Rate Comparison by Type (2021-2027) Table 2. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) Comparison by Application (2021-2027) Table 3. Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Covered in This Study Table 5. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) of Key Manufacturers (2016-2021) Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2016-2021) Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Recombinant Human Granulocyte Colony-Stimulating Average Price (USD/g) of Key Manufacturers (2016-2021) Table 10. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Manufacturing Sites and Area Served Table 11. Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Recombinant Human Granulocyte Colony-Stimulating by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Granulocyte Colony-Stimulating as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2016-2021) & (KG) Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2016-2021) Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2016-2021) & (KG) Table 19. North America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2016-2021) Table 20. North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2016-2021) Table 22. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2016-2021) & (KG) Table 23. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2016-2021) Table 24. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2016-2021) & (KG) Table 27. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2016-2021) Table 30. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2016-2021) & (KG) Table 31. Latin America Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2016-2021) Table 32. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2016-2021) & (KG) Table 35. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2016-2021) Table 38. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Type (2016-2021) Table 39. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021) Table 40. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) by Type (2016-2021) Table 41. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Type (2016-2021) Table 42. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Type (2016-2021) Table 43. Global Recombinant Human Granulocyte Colony-Stimulating Sales (KG) by Application (2016-2021) Table 44. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021) Table 45. Global Recombinant Human Granulocyte Colony-Stimulating Revenue (Million US$) by Application (2016-2021) Table 46. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Application (2016-2021) Table 47. Global Recombinant Human Granulocyte Colony-Stimulating Price (USD/g) by Application (2016-2021) Table 48. Amgen Corporation Information Table 49. Amgen Description and Business Overview Table 50. Amgen Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 51. Amgen Recombinant Human Granulocyte Colony-Stimulating Product Table 52. Amgen Recent Developments/Updates Table 53. Qilu Pharmaceutical Corporation Information Table 54. Qilu Pharmaceutical Description and Business Overview Table 55. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 56. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Table 57. Qilu Pharmaceutical Recent Developments/Updates Table 58. Shijiazhuang Pharmaceutical Corporation Information Table 59. Shijiazhuang Pharmaceutical Description and Business Overview Table 60. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 61. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Table 62. Shijiazhuang Pharmaceutical Recent Developments/Updates Table 63. Kyowa Hakko Kirin Corporation Information Table 64. Kyowa Hakko Kirin Description and Business Overview Table 65. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 66. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Table 67. Kyowa Hakko Kirin Recent Developments/Updates Table 68. Gensci Corporation Information Table 69. Gensci Description and Business Overview Table 70. Gensci Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 71. Gensci Recombinant Human Granulocyte Colony-Stimulating Product Table 72. Gensci Recent Developments/Updates Table 73. Amoytop Biotech Corporation Information Table 74. Amoytop Biotech Description and Business Overview Table 75. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 76. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Table 77. Amoytop Biotech Recent Developments/Updates Table 78. Hangzhou Jiuyuan Corporation Information Table 79. Hangzhou Jiuyuan Description and Business Overview Table 80. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 81. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Table 82. Hangzhou Jiuyuan Recent Developments/Updates Table 83. Huaxin Corporation Information Table 84. Huaxin Description and Business Overview Table 85. Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 86. Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Table 87. Huaxin Recent Developments/Updates Table 88. Triprime Corporation Information Table 89. Triprime Description and Business Overview Table 90. Triprime Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 91. Triprime Recombinant Human Granulocyte Colony-Stimulating Product Table 92. Triprime Recent Developments/Updates Table 93. Sinovac Corporation Information Table 94. Sinovac Description and Business Overview Table 95. Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 96. Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Table 97. Sinovac Recent Developments/Updates Table 98. Zhaoke Corporation Information Table 99. Zhaoke Description and Business Overview Table 100. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 101. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Table 102. Zhaoke Recent Developments/Updates Table 103. Kawin Corporation Information Table 104. Kawin Description and Business Overview Table 105. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue (Million US$), Price (USD/g) and Gross Margin (2016-2021) Table 106. Kawin Recombinant Human Granulocyte Colony-Stimulating Product Table 107. Kawin Recent Developments/Updates Table 108. Production Base and Market Concentration Rate of Raw Material Table 109. Key Suppliers of Raw Materials Table 110. Recombinant Human Granulocyte Colony-Stimulating Distributors List Table 111. Recombinant Human Granulocyte Colony-Stimulating Customers List Table 112. Recombinant Human Granulocyte Colony-Stimulating Market Trends Table 113. Recombinant Human Granulocyte Colony-Stimulating Growth Drivers Table 114. Recombinant Human Granulocyte Colony-Stimulating Market Challenges Table 115. Recombinant Human Granulocyte Colony-Stimulating Market Restraints Table 116. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2022-2027) & (KG) Table 117. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Type (2022-2027) Table 118. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Type (2022-2027) & (US$ Million) Table 119. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Type (2022-2027) Table 120. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2022-2027) & (KG) Table 121. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Application (2022-2027) Table 122. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Application (2022-2027) & (US$ Million) Table 123. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Application (2022-2027) Table 124. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Region (2022-2027) & (KG) Table 125. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Region (2022-2027) Table 126. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2022-2027) & (US$ Million) Table 127. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Region (2022-2027) Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Recombinant Human Granulocyte Colony-Stimulating Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Type in 2020 & 2027 Figure 3. Lenograstim (Granocyte) Product Picture Figure 4. Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) Product Picture Figure 5. Others Product Picture Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Application in 2020 & 2027 Figure 7. Chemotherapy Induced Neutropenia Figure 8. Before Blood Donation Figure 9. Stem Cell Transplants Figure 10. Others Figure 11. Global Recombinant Human Granulocyte Colony-Stimulating Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Market Size 2016-2027 (US$ Million) Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Sales 2016-2027 (KG) Figure 14. Global Recombinant Human Granulocyte Colony-Stimulating Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Recombinant Human Granulocyte Colony-Stimulating Sales Share by Manufacturers in 2020 Figure 16. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Recombinant Human Granulocyte Colony-Stimulating Players: Market Share by Revenue in 2020 Figure 18. Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2016-2021) Figure 20. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region in 2020 Figure 21. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2016-2021) Figure 22. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region in 2020 Figure 23. U.S. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Taiwan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Philippines Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Vietnam Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Argentina Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Turkey Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Saudi Arabia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. U.A.E Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating by Type (2016-2021) Figure 48. Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating by Application (2016-2021) Figure 49. Sales Market Share of Recombinant Human Granulocyte Colony-Stimulating by Application in 2020 Figure 50. Revenue Share of Recombinant Human Granulocyte Colony-Stimulating by Application (2016-2021) Figure 51. Revenue Share of Recombinant Human Granulocyte Colony-Stimulating by Application in 2020 Figure 52. Manufacturing Cost Structure of Recombinant Human Granulocyte Colony-Stimulating Figure 53. Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating Figure 54. Recombinant Human Granulocyte Colony-Stimulating Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

1 Recombinant Human Granulocyte Colony-Stimulating Market Overview 1.1 Product Overview and Scope of Recombinant Human Granulocyte Colony-Stimulating 1.2 Recombinant Human Granulocyte Colony-Stimulating Segment by Type 1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Lenograstim (Granocyte) 1.2.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) 1.2.4 Others 1.3 Recombinant Human Granulocyte Colony-Stimulating Segment by Application 1.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Comparison by Application: (2021-2027) 1.3.2 Chemotherapy Induced Neutropenia 1.3.3 Before Blood Donation 1.3.4 Stem Cell Transplants 1.3.5 Others 1.4 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Estimates and Forecasts 1.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue 2016-2027 1.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales 2016-2027 1.4.3 Recombinant Human Granulocyte Colony-Stimulating Market Size by Region: 2016 Versus 2021 Versus 2027 2 Recombinant Human Granulocyte Colony-Stimulating Market Competition by Manufacturers 2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2016-2021) 2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Recombinant Human Granulocyte Colony-Stimulating Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Recombinant Human Granulocyte Colony-Stimulating Manufacturing Sites, Area Served, Product Type 2.5 Recombinant Human Granulocyte Colony-Stimulating Market Competitive Situation and Trends 2.5.1 Recombinant Human Granulocyte Colony-Stimulating Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Recombinant Human Granulocyte Colony-Stimulating Players Market Share by Revenue 2.5.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario by Region 3.1 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Recombinant Human Granulocyte Colony-Stimulating Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country 3.3.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country 3.3.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country 3.4.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country 3.4.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Region 3.5.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region 3.5.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country 3.6.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country 3.6.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country 3.7.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country 3.7.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Analysis by Type 4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2016-2021) 4.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2016-2021) 4.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2016-2021) 5 Global Recombinant Human Granulocyte Colony-Stimulating Historic Market Analysis by Application 5.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2016-2021) 5.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2016-2021) 5.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Amgen 6.1.1 Amgen Corporation Information 6.1.2 Amgen Description and Business Overview 6.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.1.5 Amgen Recent Developments/Updates 6.2 Qilu Pharmaceutical 6.2.1 Qilu Pharmaceutical Corporation Information 6.2.2 Qilu Pharmaceutical Description and Business Overview 6.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.2.5 Qilu Pharmaceutical Recent Developments/Updates 6.3 Shijiazhuang Pharmaceutical 6.3.1 Shijiazhuang Pharmaceutical Corporation Information 6.3.2 Shijiazhuang Pharmaceutical Description and Business Overview 6.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.3.5 Shijiazhuang Pharmaceutical Recent Developments/Updates 6.4 Kyowa Hakko Kirin 6.4.1 Kyowa Hakko Kirin Corporation Information 6.4.2 Kyowa Hakko Kirin Description and Business Overview 6.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.4.5 Kyowa Hakko Kirin Recent Developments/Updates 6.5 Gensci 6.5.1 Gensci Corporation Information 6.5.2 Gensci Description and Business Overview 6.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.5.5 Gensci Recent Developments/Updates 6.6 Amoytop Biotech 6.6.1 Amoytop Biotech Corporation Information 6.6.2 Amoytop Biotech Description and Business Overview 6.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.6.5 Amoytop Biotech Recent Developments/Updates 6.7 Hangzhou Jiuyuan 6.6.1 Hangzhou Jiuyuan Corporation Information 6.6.2 Hangzhou Jiuyuan Description and Business Overview 6.6.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.7.5 Hangzhou Jiuyuan Recent Developments/Updates 6.8 Huaxin 6.8.1 Huaxin Corporation Information 6.8.2 Huaxin Description and Business Overview 6.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.8.5 Huaxin Recent Developments/Updates 6.9 Triprime 6.9.1 Triprime Corporation Information 6.9.2 Triprime Description and Business Overview 6.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.9.5 Triprime Recent Developments/Updates 6.10 Sinovac 6.10.1 Sinovac Corporation Information 6.10.2 Sinovac Description and Business Overview 6.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.10.5 Sinovac Recent Developments/Updates 6.11 Zhaoke 6.11.1 Zhaoke Corporation Information 6.11.2 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Description and Business Overview 6.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.11.5 Zhaoke Recent Developments/Updates 6.12 Kawin 6.12.1 Kawin Corporation Information 6.12.2 Kawin Recombinant Human Granulocyte Colony-Stimulating Description and Business Overview 6.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Kawin Recombinant Human Granulocyte Colony-Stimulating Product Portfolio 6.12.5 Kawin Recent Developments/Updates 7 Recombinant Human Granulocyte Colony-Stimulating Manufacturing Cost Analysis 7.1 Recombinant Human Granulocyte Colony-Stimulating Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating 7.4 Recombinant Human Granulocyte Colony-Stimulating Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Recombinant Human Granulocyte Colony-Stimulating Distributors List 8.3 Recombinant Human Granulocyte Colony-Stimulating Customers 9 Recombinant Human Granulocyte Colony-Stimulating Market Dynamics 9.1 Recombinant Human Granulocyte Colony-Stimulating Industry Trends 9.2 Recombinant Human Granulocyte Colony-Stimulating Growth Drivers 9.3 Recombinant Human Granulocyte Colony-Stimulating Market Challenges 9.4 Recombinant Human Granulocyte Colony-Stimulating Market Restraints 10 Global Market Forecast 10.1 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Type (2022-2027) 10.2 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Application (2022-2027) 10.3 Recombinant Human Granulocyte Colony-Stimulating Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Recombinant Human Granulocyte Colony-Stimulating by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Recombinant Human Granulocyte Colony-Stimulating by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer